Collaborators

 

Domainex Ltd is a drug discovery company that applies a novel combination of structural biology and medicinal chemistry to the development of small-molecule drugs, specifically with activity against key nucleotide triphosphate (NTP) dependent protein targets - DomaiNTaP.

 

The Company would welcome enquiries from collaborators with an interest in NTP-dependent protein targets to discuss how our technologies could assist and improve their research efforts.